Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3weeks in solid tumours: An ECSG/EORTC study

2005 ◽  
Vol 41 (5) ◽  
pp. 702-707 ◽  
Author(s):  
Alain Ravaud ◽  
Thomas Cerny ◽  
Catherine Terret ◽  
Jantien Wanders ◽  
Binh Nguyen Bui ◽  
...  
Keyword(s):  
Single Dose ◽  
Phase I ◽  
Phase I Study ◽  
Solid Tumours ◽  
Chs 828

Intravenous administration of CP-4055 (ELACYT™) in patients with solid tumours. A phase I study

2009 ◽  
Vol 48 (1) ◽  
pp. 137-145 ◽  
Author(s):  
Svein Dueland ◽  
Steinar Aamdal ◽  
Michael J. Lind ◽  
Hilary Thomas ◽  
Marit Liland Sandvold ◽  
...  
Keyword(s):  
Phase I ◽  
Intravenous Administration ◽  
Phase I Study ◽  
Solid Tumours

Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study

2017 ◽  
Vol 85 ◽  
pp. 39-48 ◽  
Author(s):  
Alain Ravaud ◽  
Carlos Gomez-Roca ◽  
Marie-Quitterie Picat ◽  
Laurence Digue ◽  
Christine Chevreau ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Phase I ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Phase I Study ◽  
Solid Tumours

scholarly journals Phase I study of single‐dose pharmacokinetics and pharmacodynamics of belatacept in adolescent kidney transplant recipients

2019 ◽  
Vol 19 (4) ◽  
pp. 1218-1223 ◽  
Author(s):  
Asha Moudgil ◽  
Vikas R. Dharnidharka ◽  
Daniel I. Feig ◽  
Barry L. Warshaw ◽  
Vidya Perera ◽  
...  
Keyword(s):  
Single Dose ◽  
Phase I ◽  
Kidney Transplant ◽  
Phase I Study ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Pharmacokinetics And Pharmacodynamics

scholarly journals First in human, a phase I study of ISU104, a novel ErbB3 monoclonal antibody, in patients with advanced solid tumours

2019 ◽  
Vol 30 ◽  
pp. v168
Author(s):  
S.-B. Kim ◽  
B. Keam ◽  
S. Shin ◽  
Y.S. Chae ◽  
T.M. Kim ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Phase I Study ◽  
Solid Tumours

scholarly journals Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours

2013 ◽  
Vol 108 (10) ◽  
pp. 1998-2004 ◽  
Author(s):  
M Millward ◽  
C Underhill ◽  
S Lobb ◽  
J McBurnie ◽  
S J Meech ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Solid Tumours

scholarly journals Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study

2014 ◽  
pp. 1723 ◽  
Author(s):  
Seokuee Kim ◽  
Jongtae Lee ◽  
Donghoon Shin ◽  
Kyoung Soo Lim ◽  
Yon Su Kim ◽  
...  
Keyword(s):  
Renal Function ◽  
Single Dose ◽  
Phase I ◽  
Phase I Study ◽  
Open Label ◽  
Open Label Phase

scholarly journals Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)

2019 ◽  
Vol 30 ◽  
pp. v565
Author(s):  
A. Hollebecque ◽  
J.S. de Bono ◽  
S. Salvagni ◽  
R. Plummer ◽  
N. Isambert ◽  
...  
Keyword(s):  
Phase I ◽  
Hodgkin Lymphoma ◽  
Phase I Study ◽  
Solid Tumours ◽  
Non Hodgkin Lymphoma
Sign in / Sign up

Export Citation Format

Share Document